AddLife acquires MBA Incorporado

a leading Spanish orthopaedic and trauma surgery business with a turnover of approximately EUR 67 million and 285 employees

AddLife is increasing its investment in digital health

AddLife acquires Telia Health Monitoring, with eight employees and sales of SEK 4 million

AddLife acquires Healthcare 21 Group

Continued expansion in Europe with new operations in Ireland and the United Kingdom

Acquisition in ophthalmology

Expansion in new segment through acquisition of Vision Ophthalmology Group

Nasdaq Stockholm Large Cap

AddLife ABs share (ALIF B) will be moved to Nasdaq Stockholm Large Cap segment effective 3 January 2022

“I am extremely proud of the development that AddLife has shown since the listing in 2016. The move to Large Cap is an important milestone, which further strengthens our position as a leading player in Life Science in Europe.” says Kristina Willgård, CEO AddLife

Another strong quarter

Interim Report Q3 2021

After almost two years of the COVID-19 pandemic, our communities are starting to re-open. The business situation in the third quarter remained favourable, influenced by the efforts of the different countries to manage the infection. Sales in the third quarter increased by 49 percent to SEK 1,850 million and the result, EBITA, increased by 44 percent to SEK 286 million and the EBITA margin amounted to 15.5 percent. Accumulated for the interim period, sales increased by 65 percent to SEK 5,862 million and EBITA rose by 94 percent to SEK 944 million.


Labtech offers products, solutions and a broad range of services in diagnostics, biomedical research and laboratory analysis.



Medtech offers products, solutions and services in medtech and home care.



We develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.



Our vision is to improve people's lives, for example by sponsoring: